News

Filter

Current filters:

IpsenManagement

Ipsen sales up 5% in 2012, though hemophilia exit hits profits; deputy CEO appointed

01-03-2013

French biopharma company Ipsen (Euronext: IPN) posted a 5% increase in drug sales in 2012 to 1.19 billion…

FinancialIpsenManagementPharmaceutical

Ipsen leaps on strong first-half results; expands links with Inspiration Biopharma and names new CFO

31-08-2011

On a very busy news days for French drugmaker Ipsen (Euronext: IPN), the company saw its shares jump…

FinancialInspiration BiopharmaceuticalsIpsenLicensingManagementPharmaceutical

Board room battle sees Ipsen’s chairman/CEO replaced; Shire names new chief for human genetics R&D

12-10-2010

French drugmaker Ipsen (Euronext: IPN) says its board of directors and its chairman, Jean-Luc Belingard,…

IpsenManagementPharmaceuticalShire

Back to top